S. 27 - Preserve Access to Affordable Generics Act
- Sponsor:
- Herb Kohl
- Summary:
- A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market. (by CRS)
- Status:
- The bill has passed through committee and has been put on a legislative calendar.
Preserve Access to Affordable Generics Act
S. 27 — 112th Congress (2011–2012)
- Summary
- A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market. (by CRS)
- Learn More
- At OpenCongress
- Title
- A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market.
- Other Titles
- Preserve Access to Affordable Generics Act
- Preserve Access to Affordable Generics Act
- Sponsor
- Herb Kohl
- Co-Sponsors
- Subjects
- Commerce
- Administrative law and regulatory procedures
- Competition and antitrust
- Contracts and agency
- Federal Trade Commission (FTC)
- Intellectual property
- Marketing and advertising
- Prescription drugs
- Related Bills
- Major Actions
Introduced 1/25/2011 Referred to Committee - Bill History
-
There have been no votes on this bill.
Action Date Description Introduced 1/25/2011 1/25/2011 Read twice and referred to the Committee on the Judiciary. 1/25/2011 Sponsor introductory remarks on measure. Put on a legislative calendar 7/21/2011 Committee on the Judiciary. Ordered to be reported without amendment favorably. 7/22/2011 Committee on the Judiciary. Reported by Senator Leahy without amendment. Without written report. Put on a legislative calendar 7/22/2011 Placed on Senate Legislative Calendar under General Orders. Calendar No. 110. Number Sponsor Date Offered Status
Contributions data source: OpenSecrets.org